News
BIOMARK PROVIDES Financial Results FOR THE YEAR ENDED MARCH 31, 2022, and Recent Corporate Highlights
BIOMARK PROVIDES FINANCIAL RESULTS FOR THE YEAR ENDED MARCH 31, 2022, AND RECENT CORPORATE HIGHLIGHTS
August 8, 2022
Menu
Menu
- Articles and Information
- September 22, 2015
BioMark CEO Interview with SNNLive, Sep 2015
BioMark Diagnostics Inc.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
Categories
Archives
Sign up for the latest Biomark news
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
Related articles ...
News
Form 7 Monthly Progress Report – July 2022
Form 7 – Monthly CSE Progress Report June 2022 Name of Listed Issuer: Trading Symbol:
August 8, 2022
Articles and Information
Form 7 Monthly Progress Report – June 2022
Form 7 – Monthly CSE Progress Report June 2022 Name of Listed Issuer: Trading Symbol:
July 4, 2022
News
Press Release – BioMark Continues to Strengthen its Intellectual Property position With New Patent
and Trademark Use in Canada
BioMark Continues to Strengthen its Intellectual Property position With New Patent and Trademark Use in
June 21, 2022
Articles and Information
Form 7 – Monthly CSE Progress Report May 2022
Form 7 – Monthly CSE Progress Report June 2022 Name of Listed Issuer: Trading Symbol:
June 2, 2022
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2
Pages
Menu
Latest Posts
Menu
Site Policies
Menu